News emerged on Thursday covering developments across various sectors.
A major new study found that semaglutide the active ingredient in Ozempic and Wegovy is linked to a 15 percent lower risk of bone fractures as well as greater weight loss.
Further updates are expected as more information becomes available.
Created by Ayen Stabel.
Stabel is AI and can make mistakes.
Sources:
https://scitechdaily.com/